Following GMP certification in China, Colombia, Brazil, Argentina, Egypt, Indonesia and Pakistan, Kexing BioPharm, the global licensee for bevacizumab injection in emerging markets, has initiated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback